Zepbound cost without insurance in 2026
Where to actually get it
Featured affiliate partners; we may earn a commission, which never changes a score. Full spread in the table below.
Zepbound lists at $1,086 a month, and almost nobody paying cash needs to pay it. Eli Lilly sells Zepbound vials directly through LillyDirect for $299/mo at the 2.5 mg starter dose, $399 at 5 mg, and $449 at 7.5 mg and above when refilled within 45 days, with a prescription. With commercial insurance that covers Zepbound, Lilly's savings card cuts a pen fill to as little as $25; the card cannot be used without insurance. Non-FDA-approved compounded tirzepatide tiers we re-checked ourselves publish from $149/mo, about 7.3x below list.
The four ways to pay, cheapest cash first
| Route | What you pay | What you are actually buying |
|---|---|---|
| Compounded tirzepatide | from $149/mo | Pharmacy-prepared product. Not FDA-approved; equivalence to Zepbound is not established. |
| LillyDirect, single-dose vials | from $299/mo | Brand Zepbound, direct from Lilly. Price rises with dose; the top rate holds only when refilled within 45 days. |
| Telehealth program, brand Zepbound | from $299/mo + fees | The same LillyDirect vial price passed through a program whose membership or clinical fee is billed separately. |
| Retail pharmacy, no discount | $1,086 | The list price. Paying this is almost always avoidable. |
Manufacturer figures verified 2026-08-07 on Lilly's own LillyDirect page. We earn nothing from the LillyDirect route and list it ahead of our own partners anyway, because it is cheaper than every brand-Zepbound tier in our index.
One number to distrust on sight: TMates lists Zepbound at $99, and that is a clinical service fee only. The medication is not included at that price.
The LillyDirect vial ladder, condition attached
The self-pay route buys single-dose vials, not the pen, and the price is a ladder rather than a number. The condition is part of the price, so it belongs next to the number: the top rate holds only when the prescription is refilled within 45 days, under the refill terms Lilly attaches to its Zepbound self-pay program. Miss the window and the regular price is higher.
| Dose | Self-pay price |
|---|---|
| 2.5 mg starter dose | $299/mo |
| 5 mg | $399/mo |
| 7.5 mg and above when refilled within 45 days | $449/mo |
The savings card is not a cash route
Coupon pages wave the $25 number at everyone. Lilly's own terms, checked August 27, 2026 on the Zepbound savings page, are narrower: the card requires commercial drug insurance that covers the Zepbound pen plus a prescription for an approved use consistent with the FDA-approved labeling. Eligible patients pay as little as $25 for a 1-month, 2-month, or 3-month pen fill, with card savings capped at $100 per 1-month fill, $200 per 2-month, $300 per 3-month, and $1,300 per calendar year. Anyone whose drugs are covered by a state, federal, or government-funded program, which includes Medicare and Medicaid, is excluded.
Read that eligibility line twice if your plan excludes weight-loss drugs: a plan that does not cover Zepbound fails the card's own first condition, so the exclusion that sent you to this page also disqualifies the coupon. That is exactly the reader the vial ladder above exists for. Full card mechanics are in our Zepbound and Mounjaro savings card guide.
Cheapest verified compounded tirzepatide right now
Compounded tirzepatide is the cheapest route, and the trade-off is regulatory rather than chemical: a compounded product is not an FDA-approved finished product, so the agency does not review it for safety, effectiveness or quality. The SURMOUNT-1 trial result everyone quotes, up to 20.9% weight loss over 72 weeks, studied the approved product at trial doses and does not establish outcomes for any compounded copy. Every tier below names tirzepatide explicitly and carries a price we re-checked ourselves; generic program headlines, which are usually semaglutide, are excluded. You will see lower numbers advertised, from $99 first-month promos, and the lowest tier meeting our flat recurring-price standard is $199/mo from Mochi Health; the full teaser-versus-flat breakdown lives on cheapest tirzepatide.
- 1Novi7.8/10 · published recurring tier; not verified as flat · price checked 2026-07-31$149/mo
- 2TMates7.8/10 · starting, as-low, or commitment rate · price checked 2026-07-31$167/moVisit
- 3Gala7.2/10 · starting, as-low, or commitment rate · price checked 2026-08-14$179/moVisit
- 4HealthRX5.2/10 · starting, as-low, or commitment rate · price checked 2026-07-31$179/moVisit
- 5Oak Longevity7.5/10 · published recurring tier; not verified as flat · price checked 2026-07-31$185/moVisit
Sorted by verified price, not by who pays us. How we rank.
Same molecule, different label, very different bill
Zepbound and Mounjaro are both tirzepatide. Zepbound carries the weight-management and obstructive sleep apnea label; Mounjaro carries the type 2 diabetes label, lists at $1,112.16/mo, and has no self-pay vial program, so a Mounjaro cash payer has no ladder to climb down. Many employer plans exclude weight-management drugs as a category, which is why an on-label drug still gets paid for in cash so often; if you are comparing molecules rather than labels, the semaglutide version of this page is Ozempic cost without insurance, and Medicare's separate Zepbound arrangement is covered in our Medicare GLP-1 coverage guide.
Frequently Asked Questions
How much does Zepbound cost without insurance?
The list price is $1,086 per month, and almost nobody paying cash needs to pay it. Eli Lilly sells Zepbound directly: LillyDirect self-pay vials, from $299/mo at the 2.5 mg starter dose, $399 at 5 mg, and $449 at 7.5 mg and above when refilled within 45 days, with a prescription. Compounded tirzepatide products are not FDA-approved, and their formulation, quality, and clinical equivalence to Zepbound are not established; tiers we re-checked ourselves publish from $149/mo.
Is the $299 LillyDirect price real?
Yes, with two conditions in the fine print. It buys single-dose vials rather than the pen, and only the 2.5 mg starter dose costs $299: the price steps up with dose, and the published rate at 7.5 mg and above holds only when the prescription is refilled within 45 days. We verified the ladder on 2026-08-07 on Lilly's own LillyDirect page.
Can I use the Zepbound savings card without insurance?
No. Lilly's terms require commercial drug insurance that covers the Zepbound pen plus a prescription for an approved use consistent with the FDA-approved labeling; eligible patients pay as little as $25 for a 1-month, 2-month, or 3-month pen fill. Card savings cap at $100 per 1-month fill, $200 per 2-month, $300 per 3-month, and $1,300 per calendar year, and anyone with state, federal, or government-funded drug coverage is excluded. The manufacturer's cash route is the LillyDirect vial ladder from $299/mo.
Is compounded tirzepatide the same as Zepbound?
No. Zepbound is an FDA-approved finished product tested as a whole. A compounded tirzepatide product is prepared for an individual patient and is not FDA-approved: the agency does not review it for safety, effectiveness, or quality before sale. Its formulation and clinical equivalence to Zepbound should not be assumed.